Mesothelioma  

Nov

14

Mesothelioma Research Funding: Miracle Foundation
By Ermenegildo Billar

Not much is known about mesothelioma, even though each year around 10,000 people die of it around the US. The first case of mesothelioma linked to asbestos inhaling was recorded as early as 1898. Then year by year more cases started to appear until now where the number reaches more than 100,000.

According to the American Journal of Respiratory and Critical Care Medicine, 1.3 million US hard workers of the construction industries and those involved in buildings and equipment maintenance are at risk of acquiring mesothelioma by inhaling asbestos. You most certainly think that a mesothelioma research funding should be started. Well you’re right, and there is! It’s called the Mesothelioma Applied Research Foundation. Their mission is to and I quote: Read more

Oct

27

Mesothelioma Surgery
By William Johnston

Mesothelioma is a rare, deadly form of cancer which can occur in a number of types. Mesothelioma is caused by exposure to asbestos, a group of natural fibres which are extremely dangerous if inhaled as fibres. When fibres are inhaled they become lodged in the alveoli of the lungs and over a period of time these fibres make tissue and cells abnormal and cause mesothelioma cancer. Pleural mesothelioma is the most common form of mesothelioma cancer, accounting for approximately 75% of all mesothelioma cases.

The next most common form, peritoneal mesothelioma, accounts for 20% of all mesothelioma cases and pericardial mesothelioma accounts for the remaining 5%. Pleural mesothelioma affects the lining of the lungs, peritoneal mesothelioma attacks the peritoneum, which is the lining of the abdomen and pericardial mesothelioma affects the tissue surrounding the heart. All three of these types of cancer occur in extremely important areas of the human body and this is one of the reasons why it is so difficult to treat. Treatment methods such as radiation therapy can only be conducted with strict radiation dosage restrictions due to the possibility of damaging a vital organ such as the lungs or the heart. Read more

Aug

22

Latest Mesothelioma Research: Combination Improves Survival
By Chris Kavila

The following mesothelioma research findings were reported in a recent issue of the Journal of Clinical Oncology. Mesothelioma researchers have reported that combining Tomudex (raltitrexed) and Platinol (cisplatin) has shown amazing results in the improved survival of patients suffering from the rare Malignant pleural mesothelioma which is caused by habitual exposure to asbestos.

According to the mesothelioma research findings reported in the journal, the combination of the two treatments dramatically improves the survival of patients compared to the use of Platinol alone.

Read more

Subscribe

Recent Articles


More Resources

Recommended Resources